Cleared Traditional

K150144 - VisuCon-F Low Fibrinogen Control Plasma

K150144 is an FDA 510(k) clearance for VisuCon-F Low Fibrinogen Control Plasma, manufactured by Affinity Biologicals, Inc.. The device is a Class 2 Hematology device with product code GGN cleared through the Traditional 510(k) pathway after a 409-day FDA review.

K150144 · Affinity Biologicals, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2016
Decision
409d
Days
Class 2
Risk

K150144 is an FDA 510(k) clearance for the VisuCon-F Low Fibrinogen Control Plasma. Classified as Plasma, Coagulation Control (product code GGN), Class II - Special Controls.

Submitted by Affinity Biologicals, Inc. (Ancaster, CA). The FDA issued a Cleared decision on March 6, 2016 after a review of 409 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Hematology submissions.

View all Affinity Biologicals, Inc. devices

FDA 510(k) Submission Details - K150144

510(k) Number K150144 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2015
Decision Date March 06, 2016
Days to Decision 409 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
296d slower than avg
Panel avg: 113d · This submission: 409d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGN Device Classification - Class 2, Special Controls

Product Code GGN Plasma, Coagulation Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGN Plasma, Coagulation Control

All 91
Devices cleared under the same product code (GGN) and FDA review panel - the closest regulatory comparables to K150144.
George King Coumadin Plasma
K161316 · George King Bio-Medical, Inc. · Feb 2017
VALIDATE® D-Dimer Calibration Verification/ Linearity Test Kit
K162705 · Maine Standards Company, LLC · Jan 2017
VALIDATE D-Dimer Calibration Verification/Linearity Test Kit
K152961 · Maine Standards Company, LLC · Jun 2016
POOL NORM
K142132 · Diagnostics Stago S.A.S. · Dec 2014
HEMOSIL D-DIMER HS 500 CONTROL
K133582 · Instrumentation Laboratory · Aug 2014
DIRECTCHECK CONTROL FOR HEMOCHRON JR. MICROCOAGULATION SYSTEMS ACT-LR CUVETTE DIRECTCHECK CONTROLS FOR HEMOCHRON JR. MIC
K120977 · International Technidyne Corp. · Jul 2013